Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) EBITDA (2024 - 2025)

Profound Medical (PROF) has 2 years of EBITDA data on record, last reported at -$7.9 million in Q4 2025.

  • For Q4 2025, EBITDA fell 14.23% year-over-year to -$7.9 million; the TTM value through Dec 2025 reached -$40.3 million, down 31.49%, while the annual FY2025 figure was -$40.3 million, 31.49% down from the prior year.
  • EBITDA reached -$7.9 million in Q4 2025 per PROF's latest filing, up from -$8.8 million in the prior quarter.
  • Across five years, EBITDA topped out at -$6.9 million in Q4 2024 and bottomed at -$13.0 million in Q2 2025.